Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients
1996 ◽
Vol 38
(0)
◽
pp. S89-S95
◽
Keyword(s):
Phase Ii
◽